|
|
|
|
Effectiveness of the standard WHO recommended retreatment regimen (Category II) for tuberculosis in Kampala,Uganda: A prospective cohort study
|
|
|
|
|
|
|
|
نویسنده
|
jones-lópez e.c. ,ayakaka i. ,levin j. ,reilly n. ,mumbowa f. ,dryden-peterson s. ,nyakoojo g. ,fennelly k. ,temple b. ,nakubulwa s. ,joloba m.l. ,okwera a. ,eisenach k.d. ,mcnerney r. ,elliott a.m. ,ellner j.j. ,smith p.g. ,mugerwa r.d.
|
|
منبع
|
plos medicine - 2011 - دوره : 8 - شماره : 3
|
|
چکیده
|
Background: each year,10%-20% of patients with tuberculosis (tb) in low- and middle-income countries present with previously treated tb and are empirically started on a world health organization (who)-recommended standardized retreatment regimen. the effectiveness of this retreatment regimen has not been systematically evaluated. methods and findings: from july 2003 to january 2007,we enrolled smear-positive,pulmonary tb patients into a prospective cohort to study treatment outcomes and mortality during and after treatment with the standardized retreatment regimen. median time of follow-up was 21 months (interquartile range 12-33 months). a total of 29/148 (20%) hiv-uninfected and 37/140 (26%) hiv-infected patients had an unsuccessful treatment outcome. in a multiple logistic regression analysis to adjust for confounding,factors associated with an unsuccessful treatment outcome were poor adherence (adjusted odds ratio [aor] associated with missing half or more of scheduled doses 2.39; 95% confidence interval (ci) 1.10-5.22),hiv infection (2.16; 1.01-4.61),age (aor for 10-year increase 1.59; 1.13-2.25),and duration of tb symptoms (aor for 1-month increase 1.12; 1.04-1.20). all patients with multidrug-resistant tb had an unsuccessful treatment outcome. hiv-infected individuals were more likely to die than hiv-uninfected individuals (p<0.0001). multidrug-resistant tb at enrolment was the only common risk factor for death during follow-up for both hiv-infected (adjusted hazard ratio [ahr] 17.9; 6.0-53.4) and hiv-uninfected (14.7; 4.1-52.2) individuals. other risk factors for death during follow-up among hiv-infected patients were cd4<50 cells/ml and no antiretroviral treatment (ahr 7.4,compared to patients with cd4≥200; 3.0-18.8) and karnofsky score <70 (2.1; 1.1-4.1); and among hiv-uninfected patients were poor adherence (missing half or more of doses) (3.5; 1.1-10.6) and duration of tb symptoms (ahr for a 1-month increase 1.9; 1.0-3.5). conclusions: the recommended regimen for retreatment tb in uganda yields an unacceptable proportion of unsuccessful outcomes. there is a need to evaluate new treatment strategies in these patients. © 2011 jones-lópez et al.
|
|
|
|
|
آدرس
|
section of infectious diseases,department of medicine,boston medical center,boston university medical school,boston,ma,united states,makerere university,university of medicine and dentistry of new jersey (umdnj) research collaboration,kampala,uganda,department of medicine,new jersey medical school -umdnj,newark,nj, United States, makerere university,university of medicine and dentistry of new jersey (umdnj) research collaboration,kampala, Uganda, medical research council-uganda virus research institute,uganda research unit on aids,entebbe,uganda,school of public health,university of the witwatersrand,johannesburg, South Africa, department of medicine,new jersey medical school -umdnj,newark,nj, United States, department of microbiology,makerere university college of health sciences,kampala, Uganda, division of infectious diseases,brigham and women's hospital,harvard medical school,boston,ma, United States, makerere university,university of medicine and dentistry of new jersey (umdnj) research collaboration,kampala, Uganda, makerere university,university of medicine and dentistry of new jersey (umdnj) research collaboration,kampala,uganda,southeastern national tuberculosis center,division of mycobacteriology,department of medicine,university of florida,gainesville,fl, United States, medical research council-uganda virus research institute,uganda research unit on aids,entebbe,uganda,menzies school of health research,darwin, Australia, medical research council-uganda virus research institute,uganda research unit on aids,entebbe, Uganda, department of microbiology,makerere university college of health sciences,kampala, Uganda, makerere university,university of medicine and dentistry of new jersey (umdnj) research collaboration,kampala,uganda,mulago hospital tuberculosis clinic,mulago hospital,kampala, Uganda, departments of pathology and,microbiology and immunology,university of arkansas for medical sciences,little rock,ar, United States, departments of infectious and tropical diseases,london school of hygiene and tropical medicine,london, United Kingdom, departments of infectious and tropical diseases,london school of hygiene and tropical medicine,london,united kingdom,department of medicine,makerere university college of health sciences,kampala, Uganda, section of infectious diseases,department of medicine,boston medical center,boston university medical school,boston,ma,united states,makerere university,university of medicine and dentistry of new jersey (umdnj) research collaboration,kampala, Uganda, epidemiology and population health,london school of hygiene and tropical medicine,london, United Kingdom, makerere university,university of medicine and dentistry of new jersey (umdnj) research collaboration,kampala,uganda,department of medicine,makerere university college of health sciences,kampala, Uganda
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Authors
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|